Synapse Open Synapse
Biology

Biogen-backed Estuary nabs $93M for kidney disease gene therapy

BioPharma Dive · · 3 min read

The Series A round, which was led by RA Capital, will help fund the development of two genetic medicines designed to treat an inherited kidney disorder known as "ADPKD."

Latest from BioPharma Dive